glp 1 drug names Market Overview: GLP-1 Agonists and the Obesity Market | Blog GLP-1 Agonists: A Comprehensive Overview
Description
Whereas, the obesity segment will expand at a significant CAGR, with the raised adoption of GLP-1 receptor agonist along with its possession of dual action are fueling the overall market growth
These protein aggregates disrupt normal brain function and contribute to the disease's progression
doi: 10.1074/jbc.M500540200 [DOI] [PubMed] [Google Scholar] 115
In the US, the advent of TrumpRx means that the prices of Wegovy and Ozempic will fall substantially even before LOE in the early 2030s (for reference, the cash-pay price of Wegovy has dropped ~33% in the last year alone), potentially softening the commercial impact of genericisation
doi: 10.1210/jcem.85.10.6855 11 FujitaYYanagimachiTTakedaYHonjoJTakiyamaYAbikoAet al
[Crossref] [PubMed] Mitchell JL, Lyons HS, Walker JK, et al
